SynthesisInternational journal of clinical practice2023

The Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: Evidence from Randomized Controlled Trials.

Fei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.